(Total Views: 145)
Posted On: 04/04/2022 1:55:30 PM
Post# of 44006

$AVCO Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
https://finance.yahoo.com/news/avalon-globoca...00211.html
https://finance.yahoo.com/news/avalon-globoca...00211.html

